Tip of the Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe by Piotr Ozieranski, Luc Martinon, Pierre-Alain Jachiet, Shai Mulinari

Connect to this object online.

Professional and governmental policy on community pharmacy: A 10-year policy review and comparative analysis (2008-2017) by Evgenia Paloumpi, Piotr Ozieranski, Margaret C. Watson, Matthew D. Jones

Connect to this object online.

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency by Piotr Ozieranski, Hiroaki Saito, Emily Rickard, Shai Mulinari, Akihiko Ozaki

Connect to this object online.

Characteristics and Distribution of Scholarship Donations From Pharmaceutical Companies to Japanese Healthcare Institutions in 2017: A Cross-sectional Analysis by Anju Murayama, Sae Kamamoto, Hiroaki Saito, Erika Yamashita, Yosuke Suzuki, Tetsuya Tanimoto, Piotr Ozieranski, Akihiko Ozaki

Connect to this object online.

How Do Institutional Conflicts of Interest Between Pharmaceutical Companies and the Healthcare Sector Become Corrupt? A Case Study of Scholarship Donations Between Department of Cl... by Akihiko Ozaki, Akihiko Ozaki, Anju Murayama, Kayo Harada, Hiroaki Saito, Toyoaki Sawano, Tetsuya Tanimoto, Piotr Ozieranski

Connect to this object online.